UBS Group AG

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1610520 ZURICH, V8

Back to PTGX Full portfolio

Position in PTGX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$416,676,508

-$129,063,189 QoQ

Shares Held

3,399,221

-34.4% QoQ

Ownership

5.25%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

of 342 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. PTGX ranks #3 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc This page	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

All Filings in PTGX

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$416,676,508	3,399,221	-34.4%	Shares	Defined	2026-08-13
2026-03-31	$545,739,697	5,177,796	+86.9%	Shares	Defined	2026-05-05
2025-12-31	$241,933,632	2,770,021	+46.1%	Shares	Defined	2026-01-29
2025-09-30	$125,951,810	1,896,008	-24.2%	Shares	Defined	2025-11-13
2025-06-30	$138,244,142	2,501,251	+608.8%	Shares	Defined	2025-08-14
2025-03-31	$17,064,839	352,871	+166.1%	Shares	Defined	2025-05-13
2024-12-31	$5,118,706	132,609	+68.3%	Shares	Defined	2025-02-14
2024-09-30	$3,545,955	78,799	+17.6%	Shares	Defined	2024-11-14
2024-06-30	$2,320,891	66,981	-62.3%	Shares	Defined	2024-08-14
2024-03-31	$5,136,405	177,546	+17.7%	Shares	Sole	2024-05-13
2023-12-31	$3,459,380	150,867	+66.3%	Shares	Sole	2024-02-09
2023-09-30	$1,513,309	90,726	+38.4%	Shares	Sole	2023-11-09
2023-06-30	$1,810,214	65,540	-43.5%	Shares	Sole	2023-08-11
2023-03-31	$2,666,597	115,939	-48.6%	Shares	Sole	2023-05-12
2022-12-31	$2,460,520	225,529	+384.2%	Shares	Sole	2023-02-08
2022-09-30	$392,669	46,580	-63.9%	Shares	Sole	2022-11-10
2022-06-30	$1,020,286	128,987	+5.1%	Shares	Sole	2022-08-10
2022-03-31	$2,907,075	122,765	+85.1%	Shares	Sole	2022-05-16
2021-12-31	$2,267,835	66,311	-4.2%	Shares	Sole	2022-02-14
2021-09-30	$1,226,488	69,215	+2491.4%	Shares	Defined	2021-11-15
2021-06-30	$119,874	2,671	-94.0%	Shares	Defined	2021-08-13
2021-03-31	$1,154,440	44,573	-31.4%	Shares	Defined	2021-05-12
2020-12-31	$1,309,048	64,933	+19.2%	Shares	Defined	2021-02-11
2020-09-30	$1,065,240	54,488	-20.7%	Shares	Sole	2020-11-12
2020-06-30	$1,213,012	68,687	-6.2%	Shares	Sole	2020-07-31
2020-03-31	$517,024	73,233	—	Shares	Sole	2020-05-01
No filing history on record for this holder in this stock.